Zijiang Yang

Novel Cell-Free Strategy for Therapeutic Angiogenesis: In Vitro Generated Conditioned Medium Can Replace Progenitor Cell Transplantation

Stefano Di Santo, Zijiang Yang, Moritz Wyler von Ballmoos et al. · PLoS ONE · 2009 · 213 citations · Full text

Life Sciences, Bioengineering, Biotechnology +15

Guselkumab for the Treatment of Crohn’s Disease: Induction Results From the Phase 2 GALAXI-1 Study

William J. Sandborn, Geert D’Haens, Walter Reinisch et al. · Gastroenterology · 2022 · 198 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

ILT4 inhibition prevents TAM- and dysfunctional T cell-mediated immunosuppression and enhances the efficacy of anti-PD-L1 therapy in NSCLC with EGFR activation

Xiaozheng Chen, Aiqin Gao, Fang Zhang et al. · Theranostics · 2021 · 172 citations · Full text

Life Sciences, Immunology, Oncology +17

A single localized dose of enzyme-responsive hydrogel improves long-term survival of a vascularized composite allograft

Thusitha Gajanayake, Radu Olariu, Franck Marie Leclère et al. · Science Translational Medicine · 2014 · 169 citations

Engineering, Biomedical Engineering, Tissue Engineering +1

PD-1 Blockade with the Monoclonal Antibody Pembrolizumab (MK-3475) in Patients with Classical Hodgkin Lymphoma after Brentuximab Vedotin Failure: Preliminary Results from a Phase 1b Study (KEYNOTE-013)

Craig H. Moskowitz, Vincent Ribrag, Jean‐Marie Michot et al. · Blood · 2014 · 154 citations

Life Sciences, Immunology, Oncology +17